This trial is testing whether or not the drug ketorolac can help to treat and prevent the progression of Diabetic Retinopathy, by reducing the levels of inflammatory mediators in the eye.
6 Primary · 2 Secondary · Reporting Duration: 3 years
Experimental Treatment
Non-Treatment Group
264 Total Participants · 2 Treatment Groups
Primary Treatment: Aqueous PGE2 and inflammatory cytokines measurements · Has Placebo Group · Phase 1
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: